HLA-DRB1*15 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis

Journal of Neuroimmunology

Volumn 210, Issue 1-2, 2009, Pages 128-130

  Imrell, Kerstin ^a   Greiner, Eva ^a   Hillert, Jan ^a   Masterman, Thomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Age of onset; HLA DRB1*15 antigen; Multiple sclerosis; Oligoclonal bands; Prognosis; Survival analysis

Indexed keywords

BIOCHEMICAL MARKER; HLA DR ANTIGEN; IMMUNOGLOBULIN G; OLIGOCLONAL BAND; BIOLOGICAL MARKER; HLA DRB1*15 ANTIGEN; HLA-DRB1*15 ANTIGEN;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; EXPANDED DISABILITY STATUS SCALE; GENETIC RISK; GENOTYPE; HEREDITY; HETEROZYGOTE DETECTION; HLA DRB1 GENE; HUMAN; IMPORT DISEASE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL; SYMPTOM; AGE; CEREBROSPINAL FLUID; DISABILITY; DISEASE COURSE; FEMALE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HETEROZYGOTE; MALE; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; ONSET AGE; PREDICTION AND FORECASTING;

ADULT; AGE FACTORS; AGE OF ONSET; BIOLOGICAL MARKERS; DISABILITY EVALUATION; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 67349107233     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.03.005     Document Type: Article

References (19)

1. Amato M.P., and Portaccio E. Clinical outcome measures in multiple sclerosis. J. Neurol. Sci. 259 (2007) 118-122
2. Andersson M., Alvarez-Cermeno J., Bernardi G., Cogato I., Fredman P., Frederiksen J., Fredrikson S., Gallo P., Grimaldi L.M., Gronning M., et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry 57 (1994) 897-902
3. Confavreux C., and Vukusic S. Age at disability milestones in multiple sclerosis. Brain 129 (2006) 595-605
4. DeLuca G.C., Ramagopalan S.V., Herrera B.M., Dyment D.A., Lincoln M.R., Montpetit A., Pugliatti M., Barnardo M.C., Risch N.J., Sadovnick A.D., Chao M., Sotgiu S., Hudson T.J., and Ebers G.C. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 20896-20901
5. Hakiki B., Goretti B., Portaccio E., Zipoli V., and Amato M.P. 'Subclinical MS': follow-up of four cases. Eur. J. Neurol. 15 (2008) 858-861
6. Imrell K., Landtblom A.M., Hillert J., and Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67 (2006) 1062-1064
7. Kantarci O., and Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr. Opin. Neurol. 19 (2006) 248-254
8. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
9. Lebrun C., Bensa C., Debouverie M., De Seze J., Wiertlievski S., Brochet B., Clavelou P., Brassat D., Labauge P., and Roullet E. Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J. Neurol. Neurosurg. Psychiatry 79 (2008) 195-198
10. Masterman T., Ligers A., Olsson T., Andersson M., Olerup O., and Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann. Neurol. 48 (2000) 211-219
11. Miller D., Weinshenker B., Filippi M., Banwell B., Cohen J., Freedman M., Galetta S., Hutchinson M., Johnson R., Kappos L., Kira J., Lublin F., McFarland H., Montalban X., Panitch H., Richert J., Reingold S., and Polman C. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult. Scler. 14 (2008) 1157-1174
12. Okuda D.T., Srinivasan R., Oksenberg J.R., Goodin D.S., Baranzini S.E., Beheshtian A., Waubant E., Zamvil S.S., Leppert D., Qualley P., Lincoln R., Gomez R., Caillier S., George M., Wang J., Nelson S.J., Cree B.A., Hauser S.L., and Pelletier D. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 132 (2009) 250-259
13. Olsson T., Kostulas V., and Link H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. Clin. Chem. 30 (1984) 1246-1249
14. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., and Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 58 (2005) 840-846
15. Roxburgh R.H., Seaman S.R., Masterman T., Hensiek A.E., Sawcer S.J., Vukusic S., Achiti I., Confavreux C., Coustans M., le Page E., Edan G., McDonnell G.V., Hawkins S., Trojano M., Liguori M., Cocco E., Marrosu M.G., Tesser F., Leone M.A., Weber A., Zipp F., Miterski B., Epplen J.T., Oturai A., Sorensen P.S., Celius E.G., Lara N.T., Montalban X., Villoslada P., Silva A.M., Marta M., Leite I., Dubois B., Rubio J., Butzkueven H., Kilpatrick T., Mycko M.P., Selmaj K.W., Rio M.E., Sa M., Salemi G., Savettieri G., Hillert J., and Compston D.A. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64 (2005) 1144-1151
16. Schmidt H., Williamson D., and Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am. J. Epidemiol. 165 (2007) 1097-1109
17. Tremlett H., Paty D., and Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology 66 (2006) 172-177
18. Trojano M., Liguori M., Bosco Zimatore G., Bugarini R., Avolio C., Paolicelli D., Giuliani F., De Robertis F., Marrosu M.G., and Livrea P. Age-related disability in multiple sclerosis. Ann. Neurol. 51 (2002) 475-480
19. Zeman A.Z., Kidd D., McLean B.N., Kelly M.A., Francis D.A., Miller D.H., Kendall B.E., Rudge P., Thompson E.J., and McDonald W.I. A study of oligoclonal band negative multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 60 (1996) 27-30